-transparent.png){kind=logo}
We hypothesized that menstrual disturbances in female athletes arise from opioid-induced abnormalities in gonadotropin and/or prolactin (PRL) secretion. To investigate this hypothesis, we measured luteinizing hormone, follicle-stimulating hormone, and PRL levels in eumenorrheic and amenorrheic athletes during thyrotropin-releasing hormone and gonadotropin-releasing hormone tests at baseline, after naloxone infusions, after exercise to exhaustion, and after similar exercise during naloxone infusions. Contrary to our hypothesis, amenorrheic runners did not have significant alterations in basal, postexercise, or stimulated hormone levels compared with eumenorrheic runners. In addition, opioid blockade by naloxone did not enhance gonadotropin release by amenorrheic athletes.
M H Samuels, and
C F Sanborn, and
F Hofeldt, and
R Robbins
September 1987,
Delaware medical journal,
M H Samuels, and
C F Sanborn, and
F Hofeldt, and
R Robbins
June 1997,
Annals of the New York Academy of Sciences,
M H Samuels, and
C F Sanborn, and
F Hofeldt, and
R Robbins
September 1985,
Clinical obstetrics and gynecology,
M H Samuels, and
C F Sanborn, and
F Hofeldt, and
R Robbins
January 1983,
Advances in shock research,
M H Samuels, and
C F Sanborn, and
F Hofeldt, and
R Robbins
March 1984,
Physiology & behavior,
M H Samuels, and
C F Sanborn, and
F Hofeldt, and
R Robbins
August 1984,
Pediatric annals,
M H Samuels, and
C F Sanborn, and
F Hofeldt, and
R Robbins
December 1984,
Hospital practice (Office ed.),
M H Samuels, and
C F Sanborn, and
F Hofeldt, and
R Robbins
August 1977,
Comprehensive therapy,
M H Samuels, and
C F Sanborn, and
F Hofeldt, and
R Robbins
February 1985,
Medicine and science in sports and exercise,
M H Samuels, and
C F Sanborn, and
F Hofeldt, and
R Robbins
May 1984,
Pharmacology, biochemistry, and behavior,
